← Evidence map

ArticleAnnals of the rheumatic diseases2022

Response to: 'Use of tanezumab for patients with hip and knee osteoarthritis with reference to a randomised clinical trial by Berenbaum and colleagues' by Riddle and Perera.

Francis Berenbaum et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2020
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 32424029